5-Year Survival Data of Durvalumab after Chemoradiotherapy for unresectable Stage III NSCLC - an Update from the PACIFIC Study


de Wit M., Spigel D., Faivre-Finn C., Gray J., Vicente D., Planchard D., ...More

STRAHLENTHERAPIE UND ONKOLOGIE, vol.197, 2021 (SCI-Expanded, Scopus) identifier

  • Publication Type: Article / Abstract
  • Volume: 197
  • Publication Date: 2021
  • Journal Name: STRAHLENTHERAPIE UND ONKOLOGIE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CINAHL, EMBASE, MEDLINE
  • Istanbul University-Cerrahpasa Affiliated: No